ACIU: AC Immune SA
ACIU exchange rate has changed by -0.80% for today. During the day, the instrument was traded at a low of 2.46 and at a high of 2.52.
Follow AC Immune SA dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ACIU News
- INSM Stock Slides on CFO Exit, Reiterates '26 Sales View
- AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know
- PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal
- Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal
- Ultragenyx's Gene Therapy for Sanfilippo Syndrome Wins EMA Validation
- Novo's Denecimig BLA Review Delayed by FDA Facility Remediation Work
- UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%
- Novo's Wegovy Pill Shows Weight Loss After Switching From Injections
- Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study
- NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk
- uniQure Plunges on Additional Data From Huntington's Disease Study
- IOVA Stock Hits 52-Week High on Raised Revenue Outlook for 2026
- Here's Why You Should Add URGN Stock to Your Portfolio Now
- Best Momentum Stock to Buy for September 30th
- AbbVie Wins FDA Nod for New Parkinson's Disease Drug Juvmo
- KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears
- Merck Inks $2.1B Deal With Chinese Biotech to Expand Oncology Pipeline
- Acadia's Daybue Patent Allowance Extends U.S. Protection to March 2041
- Teva's Branded Drugs Take Center Stage in Its Growth Strategy
- FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication
- MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy
- LLY's Olumiant Gets FDA Nod for Expanded Use in Pediatric Hair Loss
- ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal
- LLY's Onswik Wins FDA Nod as a Once-Weekly Basal Insulin for T2D
Frequently Asked Questions
What is ACIU stock price today?
AC Immune SA stock is priced at 2.47 today. It trades within 2.46 - 2.52, yesterday's close was 2.49, and trading volume reached 158. The live price chart of ACIU shows these updates.
Does AC Immune SA stock pay dividends?
AC Immune SA is currently valued at 2.47. Dividend policy depends on the company, while investors also watch -26.27% and USD. View the chart live to track ACIU movements.
How to buy ACIU stock?
You can buy AC Immune SA shares at the current price of 2.47. Orders are usually placed near 2.47 or 2.77, while 158 and 0.41% show market activity. Follow ACIU updates on the live chart today.
How to invest into ACIU stock?
Investing in AC Immune SA involves considering the yearly range 2.10 - 3.90 and current price 2.47. Many compare -6.44% and -18.48% before placing orders at 2.47 or 2.77. Explore the ACIU price chart live with daily changes.
What are AC Immune SA stock highest prices?
The highest price of AC Immune SA in the past year was 3.90. Within 2.10 - 3.90, the stock fluctuated notably, and comparing with 2.49 helps spot resistance levels. Track AC Immune SA performance using the live chart.
What are AC Immune SA stock lowest prices?
The lowest price of AC Immune SA (ACIU) over the year was 2.10. Comparing it with the current 2.47 and 2.10 - 3.90 shows potential long-term entry points. Watch ACIU moves on the chart live for more details.
When did ACIU stock split?
AC Immune SA has gone through stock splits historically. These changes are visible in , 2.49, and -26.27% after corporate actions.
- Previous Close
- 2.49
- Open
- 2.46
- Bid
- 2.47
- Ask
- 2.77
- Low
- 2.46
- High
- 2.52
- Volume
- 158
- Daily Change
- -0.80%
- Month Change
- -6.44%
- 6 Months Change
- -18.48%
- Year Change
- -26.27%
- Act
- Fcst
- 198 K
- Prev
- 199 K
- Act
- Fcst
- 1.723 M
- Prev
- 1.710 M
- Act
- Fcst
- 0.0%
- Prev
- -0.1%
- Act
- Fcst
- Prev
- 1.955%